Edition:
United Kingdom

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

25.80USD
4:51pm GMT
Change (% chg)

$-0.13 (-0.50%)
Prev Close
$25.93
Open
$25.93
Day's High
$26.18
Day's Low
$25.19
Volume
54,994
Avg. Vol
188,220
52-wk High
$26.18
52-wk Low
$12.76

Chart for

About

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs... (more)

Overall

Beta: --
Market Cap(Mil.): $1,473.30
Shares Outstanding(Mil.): 68.30
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.76 16.44
EPS (TTM): -- -- --
ROI: -- 6.38 10.61
ROE: -- 10.11 14.21

BRIEF-Diplomat Pharmacy Says Dispensing Advanced Kidney Treatment, CABOMETYX

* DIPLOMAT PHARMACY INC - ‍IS DISPENSING EXELIXIS' LIMITED-DISTRIBUTION TREATMENT CABOMETYX NOW WITH AN EXPANDED INDICATION​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

15 Jan 2018

BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook

* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​

05 Jan 2018

BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE

05 Jan 2018

BRIEF-Diplomat Completes Acquisition Of LDI Integrated Pharmacy Services

* DIPLOMAT COMPLETES ACQUISITION OF LDI INTEGRATED PHARMACY SERVICES, SECURES NEW CREDIT FACILITIES

20 Dec 2017

BRIEF-Diplomat Adds Chris Luthin As Executive Vice President

* DIPLOMAT ADDS CHRIS LUTHIN AS EXECUTIVE VICE PRESIDENT Source text for Eikon: Further company coverage:

11 Dec 2017

Diplomat Pharmacy plunges as investors fret over rapid PBM push

Shares of Diplomat Pharmacy Inc tumbled 20 percent on Thursday after the company acquired a second pharmacy benefit manager in less than a month, sparking concerns it is expanding into a business that is under heightened regulatory scrutiny.

16 Nov 2017

Diplomat Pharmacy plunges as investors fret over rapid PBM push

Nov 16 Shares of Diplomat Pharmacy Inc tumbled 20 percent on Thursday after the company acquired a second pharmacy benefit manager in less than a month, sparking concerns it is expanding into a business that is under heightened regulatory scrutiny.

16 Nov 2017

BRIEF-Diplomat to acquire LDI Integrated Pharmacy Services

* Diplomat Pharmacy Inc - ‍will pay LDI $515 million cash and approximately $80 million in diplomat common stock​

15 Nov 2017

BRIEF-Diplomat to acquire National Pharmaceutical Services

* Diplomat to acquire National Pharmaceutical Services Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

06 Nov 2017

BRIEF-Diplomat Pharmacy announces 3rd quarter financial results

* Q3 revenue $1.125 billion versus I/B/E/S view $1.16 billion

06 Nov 2017

Competitors

Earnings vs. Estimates